caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518041623

Ryszard DworskiMD

Allergy/ ImmunologyNashville, TNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Ryszard Dworski's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
VANDERBILT UNIVERSITY MEDICAL CENTER192813
Adam Guttentag
Diagnostic Radiology · Nashville, TN
40154
WORRELL, JOHN31127
Kim Sandler
Diagnostic Radiology · Nashville, TN
2867
Katherine Hartley
Diagnostic Radiology · Asheville, NC
2144
Arthur Fleischer
Diagnostic Radiology · Nashville, TN
1851
Edwin Donnelly
Diagnostic Radiology · Powell, OH
1744
John Block
Diagnostic Radiology · Nashville, TN
1647
Blake Saltaformaggio
Diagnostic Radiology · Nashville, TN
1345
Simpson Tanner
Rheumatology · Nashville, TN
1230
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
322
Unique beneficiaries
—
Total services
2,019
Distinct HCPCS
10
Medicare payment
$41K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 80 Allergy/ Immunology providers in TN — above median (cohort median 4,773).
PRESCRIBING · PART D · 2024
Total Rx claims
1,278
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
25
Brand share
65.7%
Top prescribed drugs
Omalizumab138 claims
Azithromycin126 claims
Dupilumab122 claims
Fluticasone/Umeclidin/Vilanter107 claims
Fluticasone Propionate79 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.